The Foundations of OncoPharm returns with imatinib, the 1st TKI. Discussion includes its history (and how imatinib's Phase I study almost didn't happen), uses, and toxicity.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
